[go: up one dir, main page]

GB9305919D0 - Botulinum toxin polypeptides and their use as vaccines - Google Patents

Botulinum toxin polypeptides and their use as vaccines

Info

Publication number
GB9305919D0
GB9305919D0 GB939305919A GB9305919A GB9305919D0 GB 9305919 D0 GB9305919 D0 GB 9305919D0 GB 939305919 A GB939305919 A GB 939305919A GB 9305919 A GB9305919 A GB 9305919A GB 9305919 D0 GB9305919 D0 GB 9305919D0
Authority
GB
United Kingdom
Prior art keywords
vaccines
botulinum toxin
toxin polypeptides
polypeptides
botulinum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939305919A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Public Health Laboratory Service Board
National Institute for Biological Standards and Control
Public Health England
Original Assignee
Health Protection Agency
Public Health Laboratory Service Board
National Institute for Biological Standards and Control
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Protection Agency, Public Health Laboratory Service Board, National Institute for Biological Standards and Control filed Critical Health Protection Agency
Priority to GB939305919A priority Critical patent/GB9305919D0/en
Publication of GB9305919D0 publication Critical patent/GB9305919D0/en
Priority to JP6520815A priority patent/JPH08511508A/en
Priority to AU64325/94A priority patent/AU682687B2/en
Priority to CA002158748A priority patent/CA2158748A1/en
Priority to EP94911997A priority patent/EP0690875A1/en
Priority to PCT/GB1994/000570 priority patent/WO1994021684A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GB939305919A 1993-03-22 1993-03-22 Botulinum toxin polypeptides and their use as vaccines Pending GB9305919D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB939305919A GB9305919D0 (en) 1993-03-22 1993-03-22 Botulinum toxin polypeptides and their use as vaccines
JP6520815A JPH08511508A (en) 1993-03-22 1994-03-21 Botulinum toxin polypeptide and its use as a vaccine enhancer
AU64325/94A AU682687B2 (en) 1993-03-22 1994-03-21 Botulinum toxin polypeptides and their use as vaccine enhancing agents
CA002158748A CA2158748A1 (en) 1993-03-22 1994-03-21 Botulinum toxin polypeptides and their use as vaccine enhancing agents
EP94911997A EP0690875A1 (en) 1993-03-22 1994-03-21 Botulinum toxin polypeptides and their use as vaccine enhancing agents
PCT/GB1994/000570 WO1994021684A1 (en) 1993-03-22 1994-03-21 Botulinum toxin polypeptides and their use as vaccine enhancing agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939305919A GB9305919D0 (en) 1993-03-22 1993-03-22 Botulinum toxin polypeptides and their use as vaccines

Publications (1)

Publication Number Publication Date
GB9305919D0 true GB9305919D0 (en) 1993-05-12

Family

ID=10732529

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939305919A Pending GB9305919D0 (en) 1993-03-22 1993-03-22 Botulinum toxin polypeptides and their use as vaccines

Country Status (6)

Country Link
EP (1) EP0690875A1 (en)
JP (1) JPH08511508A (en)
AU (1) AU682687B2 (en)
CA (1) CA2158748A1 (en)
GB (1) GB9305919D0 (en)
WO (1) WO1994021684A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9511909D0 (en) 1995-06-12 1995-08-09 Microbiological Res Authority Vaccine
US5919463A (en) * 1995-07-07 1999-07-06 Oravax, Inc. Clostridium difficle toxins as mucosal adjuvants
EP0837692B1 (en) * 1995-07-07 2000-08-30 Oravax, Inc. Clostridium difficile toxins and toxoids as mucosal adjuvants
US8012491B2 (en) 1996-08-23 2011-09-06 Syntaxin, Ltd. Recombinant toxin fragments
US7192596B2 (en) 1996-08-23 2007-03-20 The Health Protection Agency Ipsen Limited Recombinant toxin fragments
GB9617671D0 (en) 1996-08-23 1996-10-02 Microbiological Res Authority Recombinant toxin fragments
WO2005030119A2 (en) 2003-04-11 2005-04-07 Allergan, Inc. Botulinum toxin a peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
US20080171347A1 (en) 2003-04-11 2008-07-17 Atassi M Zouhair Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin a peptides
US7670788B2 (en) 2006-06-01 2010-03-02 Allergan, Inc. Determining and reducing immunoresistance to a Botulinum toxin therapy using Botulinum toxin B peptides
US20080118532A1 (en) 2006-06-01 2008-05-22 Atassi M Zouhair Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin b peptides

Also Published As

Publication number Publication date
AU6432594A (en) 1994-10-11
CA2158748A1 (en) 1994-09-29
WO1994021684A1 (en) 1994-09-29
EP0690875A1 (en) 1996-01-10
JPH08511508A (en) 1996-12-03
AU682687B2 (en) 1997-10-16

Similar Documents

Publication Publication Date Title
PL313133A1 (en) Antibacterial and antilichenial oxathiazines and their oxides
EP0728014A4 (en) Vaccines expressed in plants
ZA947828B (en) Vaccines
GB9013410D0 (en) Polypeptide and its use
GB9319196D0 (en) Grouting materials and their use
EP0445801A3 (en) Peptide and its use
GB9305919D0 (en) Botulinum toxin polypeptides and their use as vaccines
SG49853A1 (en) Novel macrolides and the use thereof
GB9516293D0 (en) Novel peptides and their use as vaccines
GB9315303D0 (en) Polypeptide
GB2281830B (en) I/q-modulator and i/q-demodulator
ZA9410318B (en) Phenylmethyl hexanamides and the use thereof
ZA9410217B (en) Recombinant human thymopoietin proteins and uses therefor.
GB2282601B (en) Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
IL106436A0 (en) Synthetic polypeptides and their use
EP0429860A3 (en) Shut-off and/or control element
GB9322522D0 (en) Sealing arrangements and methods
GB9302553D0 (en) Pharmaceutical preparations and their manufacture and use
GB9322702D0 (en) Vaccines
GB9501907D0 (en) Allatostatins and their use
GB9306456D0 (en) Composition and use
ZA942246B (en) Novel imidazolo-quinoxalinones their preparation and use
GB9322808D0 (en) Vaccines
IL118324A0 (en) Immunoregulatory polypeptide and its uses
GB9416643D0 (en) Bedding and related materials